Sobi, an international biopharmaceutical company transforming the lives of people affected by rare diseases, announced the launch of a new video that shows the role of interferon gamma (IFNγ) in primary hemophagocytic lymphohistiocytosis (HLH) and how Gamifant® (emapalumab-lzsg) may help.